Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Amit, Joglekar"'
Publikováno v:
Journal of Pharmacological Research and Developments. 3:16-20
A highly sensitive analytical method is developed to determine the p-toluenesulfonylurea (PTSU) and its impurities namely o-toluenesulfonamide (OTSA), p-toluenesulfonamide (PTSA) and p-toluenesulfonic acid (PTS) in Gliclazide drug substance by high p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6525705b7ba4ab86833c55ba2185c013
https://doi.org/10.46610/jprd.2021.v03i01.004
https://doi.org/10.46610/jprd.2021.v03i01.004
Publikováno v:
Journal of Biomedical and Pharmaceutical Research. 8
A simple, sensitive, specific, linear and effective Ion chromatography method has been developed and validated for the determination of Isopropylamine content in Metoprolol Succinate. Isopropylamine is possible impurity that may be present in Metopro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::29926b01220458ff7bbfe23466e8822b
https://doi.org/10.32553/jbpr.v8i5.657
https://doi.org/10.32553/jbpr.v8i5.657
Environmental pollution is majorly caused by the chemical and pharmaceutical industries which have increased multifold time in the last several decades. It is the responsibility of science to design the process which will generate the less hazardous
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63b33124f34f9b5c04bea630c6f00dd4
A rapid, sensitive and selective High performance liquid chromatography (HPLC) method was developed and validated for the trace analysis of N-(2-Chloroallyl)-1-(R)-aminoindan, a potential genotoxic impurity in Rasagiline mesylate drug substances. HPL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64d6a6327528639e9217c07c8f2783b5
Autor:
Amit, Joglekar, Fausan S, Tsai, Deborah A, McCloskey, Julianne E, Wilson, James R, Seibold, David J, Riley
Publikováno v:
The Journal of rheumatology. 33(1)
To assess the efficacy and tolerability of bosentan in pulmonary arterial hypertension secondary to systemic sclerosis (SSc-PAH) including patients with restrictive lung disease.We retrospectively reviewed 23 SSc-PAH patients with PAH at baseline [PA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cadeb56d543615789e61b25edfb29028
https://pubmed.ncbi.nlm.nih.gov/16960959
https://pubmed.ncbi.nlm.nih.gov/16960959
Publikováno v:
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. 169(8)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::62156f039458a3c73e82f6fa8ef798c6
https://pubmed.ncbi.nlm.nih.gov/14557317
https://pubmed.ncbi.nlm.nih.gov/14557317